Close
Achema middle east
swop processing & packaging

Eurogentec drug substance manufacturing facility wins FDA nod

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

GSK to Invest $30bn in the U.S. R&D and Manufacturing

GSK plc looks forward to investing $30 billion all...

$5bn Drug Manufacturing Plant in Virginia by Eli Lilly

Eli Lilly has gone on to announce its plans...

Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal

Matica Biotechnology, Inc., which happens to be a leading...

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

The FDA has granted acceptable status, under its current regulatory guidelines, to Eurogentec’s Seraing, Belgium drug substance manufacturing facility. The status will allow Eurogentec to manufacture a commercial bulk parenteral biopharmaceutical for one of its clients for the US market. Eurogentec CEO Jean-Pierre Delwart said they anticipate it as one of several future inspections as they work to bring other products closer to commercialization with their clients. Eurogentec Business Unit Director Ingrid Dheur said this demonstrates the strict cGMP compliant manufacturing and quality management system maintained at Eurogentec.

Latest stories

Related stories

GSK to Invest $30bn in the U.S. R&D and Manufacturing

GSK plc looks forward to investing $30 billion all...

$5bn Drug Manufacturing Plant in Virginia by Eli Lilly

Eli Lilly has gone on to announce its plans...

Matica Bio Gets a U.S. Biotech Commercial Manufacturing Deal

Matica Biotechnology, Inc., which happens to be a leading...

Sapio Sciences and Ultima Genomics Partner to Advance Multi-Omics Research

Partnership delivers global, end-to-end solutions to accelerate genomics research Sapio...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »